Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Sweden
- United Kingdom
- France
- Portugal
- Germany
- Spain
- Italy
- Ireland
- Canada
- Singapore
- Netherlands
- Australia
- Belgium
- Hong Kong
- Romania
- Denmark
- Norway
- Poland
- Switzerland
- Austria
- Brazil
- Czech
- Luxembourg
- Barbados
- Bulgaria
- Croatia
- Finland
- India
- Latvia
- Lithuania
- Slovenia
- Vietnam
- 23 more »
- « less
-
Program
-
Field
-
a Research Infrastructure? No Offer Description Context and scientific state of the art Oculomics, a discipline aimed at inferring systemic health from retinal biomarkers, has experienced major growth
-
to grant submissions and publication outputs. You will relish the opportunity to interact with the other biomarker teams in the NBC (https://cruknbc.org/ ), to collaborate with investigators at the CRUK
-
of their electrochemical and ECL performance; c) Functionalization of nanostructured surfaces with biomolecular probes and development of ECL assay protocols, for the detection of biomarkers or analytes of interest. Where
-
psychiatric assessments, magnetic resonance imaging, and serum biomarkers of neurodegeneration/neuroinflammation. By combining these measures, we aim to capture the full spectrum of epilepsy-related
-
with the other biomarker teams in the NBC (https://cruknbc.org/ ), to collaborate with investigators at the CRUK Manchester Institute and will maximise the location of the NBC within the Manchester
-
biomarkers and their integration with nanoplasmonic sensors to develop next-generation, non-invasive platforms for disease detection and longitudinal monitoring. The Role Led by Prof. Dan Lambert and a
-
, based on biomarker and micronutrient intake data and developing context-specific, food-focused solutions to ensure adequate supply of vitamins and minerals from diets from sustainable sources. Using high
-
clinical trials and immune-oncology (IO) treatments. The main duties & responsibilities of the post-holder are dependent on (1) the specific project or clinical trial and (2) the biomarker strategy and
-
analytics of high-resolution physiological data and other biomarkers. The group applies machine learning tools to better understand the pathophysiology of acute brain injuries with a focus on disorders of
-
on the analysis and development of biomarker profiles for the personalized assessment of cardiovascular risks associated with cancer therapy. You will be responsible for: Conducting proteomic analyses of blood